A big-scale international collaborative study lead by Professor Jacques Simard from Université Laval and Professor Douglas Easton on the University of Cambridge, UK, has identified latest genes related to breast cancer that might eventually be included in tests to discover women at increased risk. Current genetic tests for breast cancer only consider a couple of […]
Poolbeg Pharma, a clinical-stage biopharmaceutical company specializing in infectious and other prevalent diseases with a high unmet medical need, declares a big breakthrough in its world first influenza Artificial Intelligence (‘AI’) Programme with CytoReason. Poolbeg has been working with CytoReason since March 2022. Poolbeg’s unique disease progression data from influenza human challenge trials combined with CytoReason’s […]
Colorectal cancer incidence and deaths are declining for people age 50 and older, but are increasing for those under 50. A brand new study, led by researcher-clinician Thomas Imperiale, M.D., of the U.S. Department of Veterans Affairs, Regenstrief Institute and Indiana University School of Medicine, identifies seven risk aspects for early onset colorectal cancer in […]